Lyra Therapeutics Inc (LYRA) — Defensive Interval Ratio
Lyra Therapeutics Inc (LYRA) has a Defensive Interval Ratio of 0 days as of December 2024. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $34.61K/day. See how liquid is Lyra Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Lyra Therapeutics Inc Defensive Interval Ratio (2018–2024)
This chart shows how Lyra Therapeutics Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2018 to 2024. As of December 2024, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See Lyra Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Lyra Therapeutics Inc (2018–2024)
The table below presents the year-by-year Defensive Interval Ratio for Lyra Therapeutics Inc from 2018 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LYRA market cap.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 0 days | $0.00 | $34.61K/day | $- | $0.00 | ▼ -1497 days |
| 2023 | 1497 days | $80.40 Million | $53.69K/day | $- | $80.40 Million | ▼ -151 days |
| 2022 | 1648 days | $65.34 Million | $39.64K/day | $- | $65.34 Million | ▲ +1648 days |
| 2021 | 0 days | $0.00 | $49.99K/day | $- | $0.00 | ▼ -31 days |
| 2018 | 31 days | $167.00K | $5.37K/day | $- | $- | — |